{"title":"肝移植候选人门静脉血栓形成的危险因素。","authors":"Cagatay Ak, Gupse Adali, Suleyman Sayar, Abdulbaki Agackiran, Fatma Kulali, Resul Kahraman, Oguzhan Ozturk, Kamil Ozdil","doi":"10.14744/hf.2022.2022.0005","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aim: </strong>Portal vein thrombosis (PVT) is particularly detected in advanced liver cirrhosis patients. We aimed to analyze the risk factors for PVT in liver transplant candidates.</p><p><strong>Materials and methods: </strong>Dataset for consecutive 165 cirrhotic patients who were evaluated for liver transplantation (LT) were retrospectively analyzed. We sorted patients into two groups: patients with PVT and patients without PVT. Included variables were age, sex, etiology of liver disease, body mass index, MELD-Na score, Child-Pugh score, clinical variables reflecting portal hypertension, and hepatocellular carcinoma. Univariate and multivariate logistic regression analyses were used to identify risk factors of PVT.</p><p><strong>Results: </strong>Of 165 LT candidates, 46 had PVT (27.9%). Ascites, thrombocytopenia, history of variceal bleeding, and band ligation were risk factors for PVT in univariate analysis. In multivariate analysis, only a history of variceal bleeding (OR 3.45, 95% CI 1.02-11.6, p=0.046) significantly increased the risk of PVT.</p><p><strong>Conclusion: </strong>The previous history of variceal bleeding predicts PVT development in cirrhosis, suggesting that the severity of portal hypertension is a major predictive factor for PVT in patients with cirrhosis. Future prospective studies are needed to risk stratifying cirrhosis patients prior to LT for future PVT development and to define the prophylactic role of anticoagulation in these patients.</p>","PeriodicalId":29722,"journal":{"name":"Hepatology Forum","volume":"3 3","pages":"88-92"},"PeriodicalIF":1.2000,"publicationDate":"2022-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b2/8a/hf-3-088.PMC9510737.pdf","citationCount":"4","resultStr":"{\"title\":\"Portal vein thrombosis risk factors in liver transplant candidates.\",\"authors\":\"Cagatay Ak, Gupse Adali, Suleyman Sayar, Abdulbaki Agackiran, Fatma Kulali, Resul Kahraman, Oguzhan Ozturk, Kamil Ozdil\",\"doi\":\"10.14744/hf.2022.2022.0005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and aim: </strong>Portal vein thrombosis (PVT) is particularly detected in advanced liver cirrhosis patients. We aimed to analyze the risk factors for PVT in liver transplant candidates.</p><p><strong>Materials and methods: </strong>Dataset for consecutive 165 cirrhotic patients who were evaluated for liver transplantation (LT) were retrospectively analyzed. We sorted patients into two groups: patients with PVT and patients without PVT. Included variables were age, sex, etiology of liver disease, body mass index, MELD-Na score, Child-Pugh score, clinical variables reflecting portal hypertension, and hepatocellular carcinoma. Univariate and multivariate logistic regression analyses were used to identify risk factors of PVT.</p><p><strong>Results: </strong>Of 165 LT candidates, 46 had PVT (27.9%). Ascites, thrombocytopenia, history of variceal bleeding, and band ligation were risk factors for PVT in univariate analysis. In multivariate analysis, only a history of variceal bleeding (OR 3.45, 95% CI 1.02-11.6, p=0.046) significantly increased the risk of PVT.</p><p><strong>Conclusion: </strong>The previous history of variceal bleeding predicts PVT development in cirrhosis, suggesting that the severity of portal hypertension is a major predictive factor for PVT in patients with cirrhosis. Future prospective studies are needed to risk stratifying cirrhosis patients prior to LT for future PVT development and to define the prophylactic role of anticoagulation in these patients.</p>\",\"PeriodicalId\":29722,\"journal\":{\"name\":\"Hepatology Forum\",\"volume\":\"3 3\",\"pages\":\"88-92\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2022-09-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b2/8a/hf-3-088.PMC9510737.pdf\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hepatology Forum\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14744/hf.2022.2022.0005\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/9/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hepatology Forum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14744/hf.2022.2022.0005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/9/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 4
摘要
背景与目的:门静脉血栓形成(PVT)在晚期肝硬化患者中尤为常见。我们的目的是分析肝移植候选人PVT的危险因素。资料和方法:回顾性分析连续165例评估肝移植(LT)的肝硬化患者的数据集。我们将患者分为两组:PVT患者和无PVT患者,纳入的变量包括年龄、性别、肝病病因、体重指数、MELD-Na评分、Child-Pugh评分、反映门脉高压的临床变量和肝细胞癌。采用单因素和多因素logistic回归分析确定PVT的危险因素。结果:165例LT患者中,46例有PVT(27.9%)。在单因素分析中,腹水、血小板减少、静脉曲张出血史和绑扎是PVT的危险因素。在多因素分析中,只有静脉曲张出血史(OR 3.45, 95% CI 1.02-11.6, p=0.046)显著增加了PVT的风险。结论:既往静脉曲张出血史可预测肝硬化患者PVT的发展,提示门脉高压的严重程度是肝硬化患者PVT的主要预测因素。未来的前瞻性研究需要对肝移植前肝硬化患者进行风险分层,以预防未来PVT的发展,并确定抗凝治疗在这些患者中的预防作用。
Portal vein thrombosis risk factors in liver transplant candidates.
Background and aim: Portal vein thrombosis (PVT) is particularly detected in advanced liver cirrhosis patients. We aimed to analyze the risk factors for PVT in liver transplant candidates.
Materials and methods: Dataset for consecutive 165 cirrhotic patients who were evaluated for liver transplantation (LT) were retrospectively analyzed. We sorted patients into two groups: patients with PVT and patients without PVT. Included variables were age, sex, etiology of liver disease, body mass index, MELD-Na score, Child-Pugh score, clinical variables reflecting portal hypertension, and hepatocellular carcinoma. Univariate and multivariate logistic regression analyses were used to identify risk factors of PVT.
Results: Of 165 LT candidates, 46 had PVT (27.9%). Ascites, thrombocytopenia, history of variceal bleeding, and band ligation were risk factors for PVT in univariate analysis. In multivariate analysis, only a history of variceal bleeding (OR 3.45, 95% CI 1.02-11.6, p=0.046) significantly increased the risk of PVT.
Conclusion: The previous history of variceal bleeding predicts PVT development in cirrhosis, suggesting that the severity of portal hypertension is a major predictive factor for PVT in patients with cirrhosis. Future prospective studies are needed to risk stratifying cirrhosis patients prior to LT for future PVT development and to define the prophylactic role of anticoagulation in these patients.